Integrity of the permeability barrier regulates epidermal Langerhans cell density.
Previous studies have shown that barrier requirements regulate epidermal liquid and DNA synthesis. In the present study, we examined the possibility that the integrity of the permeability barrier influences epidermal Langerhans cells involved with the immune response. Barrier disruption was achieved by treatment of human skin with acetone, sodium dodecylsulphate (SDS), or tape stripping, until a 10-20-fold increase in transepidermal water loss was achieved. Serial biopsies were performed 6-168 h after treatment, and Langerhans cells were complexed with anti-CD1a (Leu6) or S-100 antibodies, and visualized with an immunoperoxidase technique. Acetone treatment resulted in an increase in epidermal Langerhans cell density, reaching a maximum of 94% over control (P < 0.01) by 24 and 48 h post-treatment. Following SDS treatment or tape stripping, epidermal Langerhans cell density was increased by 100 and 175% (P < 0.01), respectively. There was a linear correlation between the degree of barrier disruption and the increase in epidermal Langerhans cell density. Studies with the Ki-S3 proliferation-associated nuclear antigen revealed a two- to threefold increase in epidermal proliferation after barrier disruption. The time curves of the increase in Langerhans cell density and the increase in epidermal proliferation were similar, suggesting that there was a coordinate regulation. In contrast with our previous studies employing patch test reactions to allergens or irritants, disruption of barrier function neither resulted in an increased dermal Langerhans cell density, nor influenced T lymphocytes (CD3+, Leu4+), macrophages (KiM8+), ICAM-1 or ELAM-1 expression in the skin. In addition, barrier disruption did not result in either dermal inflammation or epidermal spongiosis. In summary, these findings support our hypothesis that the permeability barrier influences epidermal Langerhans cell density, which is involved in maintaining an immunological barrier.
Proksch
E
E
Department of Dermatology, University of Kiel, Germany.
Brasch
J
J
Sterry
W
W
D000096:Acetone / Q000494:pharmacology; D002452:Cell Count / Q000187:drug effects; D002455:Cell Division / Q000187:drug effects; D004817:Epidermis / Q000276:immunology*; D006801:Humans; D007124:Immunoenzyme Techniques; D007801:Langerhans Cells / Q000166:cytology*; D009779:Occlusive Dressings; D010539:Permeability / Q000187:drug effects; D012867:Skin / Q000276:immunology; D012869:Skin Absorption / Q000187:drug effects / Q000276:immunology*; D012967:Sodium Dodecyl Sulfate / Q000494:pharmacology; D014870:Water Loss, Insensible / Q000187:drug effects
D000096:Acetone; D012967:Sodium Dodecyl Sulfate